Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |